Aminobenzoic acids and derivatives
Cambridge Isotope Laboratories 3-Plex SILAC Amino Acid Standards ea
3-Plex SILAC Amino Acid Standards ea
Medchemexpress LLC (4R)-5-(dipentylamino)-5-oxo-4-(quinoline-3-carbonylamino)pentanoic acid | 119295-94-2 | 99.9% | 441.56 g/mol | C25H35N3O4 | 1 MG
A selective cholecystokinin A (CCK-A) receptor antagonist used in research to inhibit CCK8-induced amylase secretion. Supplied as a high-purity, white to off-white solid with recommended cold storage to maintain stability.
- Selective CCK-A receptor antagonist for receptor pharmacology studies.
- High purity suitable for biochemical and cellular assays.
- White to off-white solid appearance for easy visual inspection.
- Stable under recommended cold storage for extended shelf life.
- Compatible with common in vitro solvent systems when handled as directed.
Accela Chembio Inc 2-amino-3 | 4-dimethylbenzoic Acid | 25g | 50419-58-4 | MFCD00130041 | 97+% | Shelf Life: 2160 Days | Light Sensitive
2-amino-3 | 4-dimethylbenzoic Acid | 25g | 50419-58-4 | MFCD00130041 | 97+% | Shelf Life: 2160 Days | Light Sensitive
Medchemexpress LLC 4-chloro-2-methoxybenzonitrile | 100960-68-7 | MFCD09865166 | 100mg
4-Chloro-2-methoxybenzonitrile is a drug impurity
Sigma Aldrich Fine Chemicals Biosciences Alzheimers In A DishTM APP
Amyloid-beta plagues and neurofibrillary tangles are key pathological features observed in the brains of Alzheimers patients. Familial early onset forms of AD (FAD) are caused by autosomal dominant inherited genetic mutations and offer an opportunity to study the effects of key mutations on the diseases progression and pathology. To date approximately 200 FAD mutations in APP and/or PSEN1 have been reported. Transgenic mouse models and human neurons harboring FAD mutations in PSEN-1 and/or APP are widely used as model systems and have provide important insights into the disease. Transgenic mouse models are able to recapitulate the loss in cognitive functions along with increased deposition of b-amyloid plagues but are unable to demonstrate neurofibrillary tangles one of the key pathological hallmarks of AD. Similarly human iPSC-derived neurons from FAD patients demonstrated increased levels of the pathogenic AB species and phosphorylated tau but lack the characteristic amyloid-bet
Medchemexpress LLC 2-amino-5-fluoropyridine | 21717-96-4 | MFCD01861120 | 99.9% | 112.11 g/mol | C5H5FN2 | 500g
2-Amino-5-fluoropyridine is a drug intermediate for synthesis of various active compounds
Sigma Aldrich Fine Chemicals Biosciences Soyasapogenol A phyproofR10MG
This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity water residual solvents inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH Co. KG
Apexbio Technology LLC Pefloxacin Mesylate Dihydrate 149676-40-4 10mM (in 1mL DMSO)
Pefloxacin mesylate dihydrate is a third-generation fluoroquinolone antibacterial compound which functions through the inhibition of bacterial DNA gyrase (a type II DNA topoisomerase) By interfering with DNA gyrase activity pefloxacin mesylate dihydrate inhibits bacterial DNA replication and promotes bacterial cell death As an antibacterial agent this compound is commonly applied in biological research to study bacterial resistance pathways DNA gyrase inhibitory mechanisms and novel antimicrobial approaches In antimicrobial susceptibility assays pefloxacin mesylate displays inhibitory potency with reported IC50 values generally within the low micromolar range varying depending on bacterial strains and experimental conditions Researchers utilize this compound widely to investigate its antibacterial efficacy resistance development and mechanisms underlying drug-target interactions
Medchemexpress LLC Encequidar mesylate | 849675-87-2 | MFCD25976626 | 99.8% | C39H40N6O10S | 10MG
Encequidar mesylate is a competitive and selective P-glycoprotein (P-gp) inhibitor used in research to investigate P-gp-mediated drug transport and to evaluate strategies for improving oral absorption of P-gp substrate drugs. Supplied as the mesylate salt with confirmed high purity for analytical and preclinical studies.
- Competitive and selective P-glycoprotein inhibitor.
- Mesylate salt form for handling and stability.
- Facilitates studies of intestinal and cellular P-gp transport.
- Used to evaluate oral bioavailability enhancement strategies.
- High purity (99.8%) for consistent experimental results.
- Chemical formula C39H40N6O10S and molecular weight 784.83 g/mol.
- Suitable for in vitro and in vivo preclinical research.